Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus

Clinical trial NCT00467376 · COMPLETED

Trial details

NCT number: NCT00467376
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2007-01-01
Primary completion: 2008-06-01
Enrollment: 485

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.